Journal of Multiple Sclerosis and Neuroimmunology

Search

Page Path

HOME
Search

Review Article

Rituximab Treatment for Neuroimmunologic Disorders: Ilhan Yoo; J Mult Scler Neuroimmunol. 2023;14(1):44-50. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.44; Full text PubReader ePub PDF

Review Article

New Therapeutic Agents in Myasthenia Gravis: Jinhee Kim, Ha Young Shin; J Mult Scler Neuroimmunol. 2023;14(1):34-43. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.34; Full text PubReader ePub PDF

Review Article

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review: Young Nam Kwon, Sung-Min Kim; J Mult Scler Neuroimmunol. 2023;14(1):24-33. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.24
Cited By 1; Full text PubReader ePub PDF

Review Article

Monoclonal Antibody Therapies for Neuromyelitis Optica Spectrum Disorder: Woojun Kim; J Mult Scler Neuroimmunol. 2023;14(1):15-23. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.15; Full text PubReader ePub PDF

Review Article

Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis: Je-Young Shin, Suk-Won Ahn; J Mult Scler Neuroimmunol. 2023;14(1):9-14. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.9; Full text PubReader ePub PDF

Review Article

Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria: Jiwon Yang; J Mult Scler Neuroimmunol. 2023;14(1):1-8. Published online June 30, 2023; DOI: https://doi.org/10.59578/jmsni.2023.14.1.1; Full text PubReader ePub PDF

Neuroimage

Unilateral Dominant Pachymeningitis in ANCA-associated Vasculitis: Euihyun Sung, Young Seo Kim; J Mult Scler Neuroimmunol. 2022;13(2):39-40. Published online December 31, 2022; PDF

Case Report

A Case of Parkinsonism after Asymptomatic COVID-19 Infection Treated with High-Dose Corticosteroid: Yu-Jin Kang, Ga Eun Koo, Yi-Seul Choo, Moonho Won, Chan-Young Park; J Mult Scler Neuroimmunol. 2022;13(2):35-38. Published online December 31, 2022; PDF

Case Report

Favorable Response to Rituximab in a Patient with Recurrent Primary Angiitis of the Central Nervous System: A Case Report and Literature Review: Tae Young Kim, Yong Jin Kim, Min Kim, Jae Hyun Jeon, Hyun-Mi Park, Dong Hoon Shin, Jiwon Yang; J Mult Scler Neuroimmunol. 2022;13(2):30-34. Published online December 31, 2022; PDF

Review Article

Autoimmune Nodopathies: Hyun Ji Lyou, Ha Young Shin; J Mult Scler Neuroimmunol. 2022;13(2):23-29. Published online December 31, 2022; PDF

Brief Communication

Neuromyelitis Optica Spectrum Disease Misdiagnosed as Atypical Anorexia Nervosa: A case report: Jiwon Lee; J Mult Scler Neuroimmunol. 2022;13(1):19-21. Published online June 1, 2022; PDF

Brief Communication

A Case of Optic Neuritis after COVID-19 Infection: Sung-Yeon Sohn; J Mult Scler Neuroimmunol. 2022;13(1):16-18. Published online June 1, 2022; PDF

Case Report

Favorable Response to Corticosteroid Treatment in Chronic Inflammatory Axonal Polyneuropathy: Jiwon Yang; J Mult Scler Neuroimmunol. 2022;13(1):12-15. Published online June 1, 2022; PDF

Case Report

Neuro-Sweet Disease Presenting as Meningitis: Bit Na Lee; J Mult Scler Neuroimmunol. 2022;13(1):8-11. Published online June 1, 2022; PDF

Review Article

Neurological Manifestations and Mechanisms in COVID-19: Jin-Hyung Lee, So-young Huh; J Mult Scler Neuroimmunol. 2022;13(1):1-7. Published online June 1, 2022; PDF

Volume 17, No. 1

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

4,756	National Consensus Guidance for Management of Refractory Myasthenia Gravis
4,705	Autoimmune Nodopathy: When to Suspect and How to Treat?
2,778	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
2,670	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis
2,245	Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis

Cited By 3	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis
Cited By 1	Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.